Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 756,553 |
|
|||||
| News | (2) | ||||||
| Day High | 16.71 | Low High |
|||||
| Day Low | 15.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.30 | -1.81% | 16.23 | 00:00:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.71 | 15.75 | 16.71 | 15.86 | 16.53 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,287 | 756,553 | $ 16.06 | $ 12,147,081 | - | 11.33 - 25.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:53:10 | 2 | $ 16.20 | USD |
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 524.71M | 33.10M | - | 25.82M | -62.09M | -1.88 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.50 | 17.98 | 15.75 | 16.68 | 535,385 | -1.27 | -7.26% |
| 1 Month | 14.93 | 19.34 | 14.87 | 17.01 | 715,101 | 1.30 | 8.71% |
| 3 Months | 15.49 | 19.34 | 12.57 | 16.09 | 534,157 | 0.74 | 4.78% |
| 6 Months | 16.84 | 25.25 | 12.57 | 17.24 | 467,966 | -0.61 | -3.62% |
| 1 Year | 16.81 | 25.25 | 11.33 | 16.74 | 293,057 | -0.58 | -3.45% |
| 3 Years | 24.35 | 63.69 | 10.8001 | 18.58 | 151,007 | -8.12 | -33.35% |
| 5 Years | 18.30 | 63.69 | 10.8001 | 18.65 | 148,036 | -2.07 | -11.31% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
